Nanologica AB (4YD) Stock Statistics & Valuation Metrics

Nanologica AB has a market cap or net worth of €12.27M. The enterprise value is €82.85M.

Nanologica AB has 88,357,230 shares outstanding. The number of shares has decreased by -2.65% in one year.

Nanologica AB’s return on equity (ROE) is -0.89 and return on invested capital (ROIC) is -47.40%.

The current PE Ratio of Nanologica AB is ―. Nanologica AB’s PEG ratio is 0.04.

In the last 12 months, Nanologica AB had revenue of 14.54M and earned -65.63M in profits. Earnings per share was -1.32.

In the last 12 months, operating cash flow was -69.29M and capital expenditures -45.00K, giving a free cash flow of -69.33M billion.

Nanologica AB pays an annual dividend of ―, resulting in a dividend yield of ―

Nanologica AB upcoming earnings date is Oct 23, 2025, TBA (Confirmed).

Nanologica AB as a current ratio of 1.65, with Debt / Equity ratio of 13.04%

In the past 12 months, Nanologica AB has paid 35.00K in taxes.

Nanologica AB EV to EBITDA ratio is -2.05, with an EV/FCF ratio of -1.14.

Nanologica AB has €26.38M in cash and marketable securities with €6.73M in debt, giving a net cash position of -€19.65M billion.

Gross margin is 9.92%, with operating margin of -407.59%, and net profit margin of -451.43%.

The average price target for Nanologica AB is €0.13, which is 11.43% higher than the current price. The consensus rating is Hold